Cabri P

No ORCID on file · 3 papers in corpus
nonrandomized-trial 2023
Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study
Advances in therapy ·doi:10.1007/s12325-023-02617-8

INTRODUCTION: Triptorelin is available as 1- and 3-month prolonged-release (PR) formulations; at the time of the study, only the former was approved for central precocious puberty (CPP) in China. This study assessed the efficacy and safety …

rct 2022
Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial
Advances in therapy ·doi:10.1007/s12325-022-02264-5

INTRODUCTION: This phase 3, randomized, open-label, active-controlled, multicenter study investigated the efficacy of triptorelin pamoate prolonged-release (PR) 3-month in Chinese patients with endometriosis by demonstrating the noninferior…

observational 2016
Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study
Advances in therapy ·doi:10.1007/s12325-016-0366-x

INTRODUCTION: The present study aimed to investigate clinical, lifestyle, and environmental factors associated with endometrioma (OMA) and/or deep infiltrating endometriosis (DIE) as determined by case-control comparison [women with superfi…